AU564956B2 - Antimycotic agent - Google Patents

Antimycotic agent

Info

Publication number
AU564956B2
AU564956B2 AU26236/84A AU2623684A AU564956B2 AU 564956 B2 AU564956 B2 AU 564956B2 AU 26236/84 A AU26236/84 A AU 26236/84A AU 2623684 A AU2623684 A AU 2623684A AU 564956 B2 AU564956 B2 AU 564956B2
Authority
AU
Australia
Prior art keywords
antimycotic agent
antimycotic
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU26236/84A
Other languages
English (en)
Other versions
AU2623684A (en
Inventor
Karlheinz Adams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2623684A publication Critical patent/AU2623684A/en
Application granted granted Critical
Publication of AU564956B2 publication Critical patent/AU564956B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AU26236/84A 1983-03-30 1984-03-29 Antimycotic agent Expired AU564956B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3311701 1983-03-30
DE19833311701 DE3311701A1 (de) 1983-03-30 1983-03-30 Antimykotische mittel mit hoher wirkstoff-freisetzung in form von creme

Publications (2)

Publication Number Publication Date
AU2623684A AU2623684A (en) 1984-10-04
AU564956B2 true AU564956B2 (en) 1987-09-03

Family

ID=6195162

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26236/84A Expired AU564956B2 (en) 1983-03-30 1984-03-29 Antimycotic agent

Country Status (19)

Country Link
JP (1) JPS59184106A (it)
KR (1) KR840008284A (it)
AU (1) AU564956B2 (it)
BE (1) BE899278A (it)
CA (1) CA1212327A (it)
CH (1) CH660126A5 (it)
CY (1) CY1358A (it)
DE (1) DE3311701A1 (it)
ES (3) ES8503947A1 (it)
FR (1) FR2543435B1 (it)
GB (1) GB2137091B (it)
GR (1) GR81485B (it)
IT (1) IT1173761B (it)
KE (1) KE3704A (it)
LU (1) LU85271A1 (it)
PH (1) PH20420A (it)
PT (1) PT78313B (it)
SE (1) SE8401748L (it)
ZA (1) ZA842337B (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
ZA934007B (en) * 1992-06-08 1994-03-09 Schering Plough Healthcare Stable imidazole anti-fungal powder compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2461406C2 (de) * 1974-12-24 1984-06-14 Bayer Ag, 5090 Leverkusen Azolyl-(1)-methane und deren Salze, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE3045914A1 (de) * 1980-12-05 1982-07-22 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3045915A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3045913A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung
DE3106635A1 (de) * 1981-02-23 1982-09-09 Bayer Ag Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von stiften

Also Published As

Publication number Publication date
CY1358A (en) 1987-08-07
SE8401748L (sv) 1984-10-01
CA1212327A (en) 1986-10-07
IT1173761B (it) 1987-06-24
ES8601692A1 (es) 1985-11-16
GB8408067D0 (en) 1984-05-10
GR81485B (it) 1984-12-11
JPS59184106A (ja) 1984-10-19
DE3311701A1 (de) 1984-10-04
ES8601693A1 (es) 1985-11-16
SE8401748D0 (sv) 1984-03-29
CH660126A5 (de) 1987-03-31
BE899278A (fr) 1984-10-01
AU2623684A (en) 1984-10-04
PH20420A (en) 1987-01-05
FR2543435B1 (fr) 1988-06-17
PT78313A (en) 1984-04-01
ES530846A0 (es) 1985-04-16
KE3704A (en) 1987-03-27
IT8420303A0 (it) 1984-03-29
ZA842337B (en) 1984-11-28
PT78313B (en) 1986-06-02
GB2137091B (en) 1986-10-01
ES539289A0 (es) 1985-11-16
ES8503947A1 (es) 1985-04-16
LU85271A1 (de) 1984-11-14
KR840008284A (ko) 1984-12-14
GB2137091A (en) 1984-10-03
ES539290A0 (es) 1985-11-16
FR2543435A1 (fr) 1984-10-05

Similar Documents

Publication Publication Date Title
AU561591B2 (en) line
AU559288B2 (en) Fungicidal agents
AU2773884A (en) Pyridyl- and pyrimidyl- sulphonamides
AU2670684A (en) N-aryl-alpha-amino-carboxamides
AU574360B2 (en) Antisnoring agent
AU2768784A (en) Carry-cot
AU2478684A (en) Branch-copolymers
AU559700B2 (en) Fungicidal agents
AU2449484A (en) N-piperazinylalkanoylanilides
AU2692984A (en) Benzoquinolizines
AU2743684A (en) 4-phenyl-tetrahydro-furano-pyridines
AU564979B2 (en) Antimycotic agent
AU3419584A (en) Mud-conditioning agent
AU2543484A (en) Sky-light
AU564956B2 (en) Antimycotic agent
AU2445584A (en) D-homosteroids
AU2454184A (en) Aroylimidazolones
AU564421B2 (en) Lipoteictioic acid antitomor agent
AU2610884A (en) Benzobisoxazinetetra-ones
AU2682284A (en) Diphenylazomethines
AU2580684A (en) Pyridyl-benzoxazines
AU2745984A (en) N-cyclohexadienyl-chloroacetamides
AU567780B2 (en) Chlorocefadroxil monohydrate
AU2680884A (en) Fungicidal agents
AU2610084A (en) 4-substituted-2-azetidinones

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired